Prospective assessment of clinical outcomes in patients with lung cancer;Evaluación prospectiva de resultados clínicos en los pacientes con cáncer de pulmón

Medicina Clinica

Volumn 114, Issue SUPPL. 3, 2000, Pages 104-111

  Bonfill, Xavier ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Assessment; Clinical outcomes; Effectiveness; Lung cancer; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SICKNESS IMPACT PROFILE; SPAIN; SURVIVAL;

ADULT; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SICKNESS IMPACT PROFILE; SPAIN; SURVIVAL ANALYSIS;

EID: 0033647670     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bergman B, Aaronson NK. Quality-of-life and cost-effectiveness assessment in lung cancer. Curr Opin Oncol 1995; 7: 138-143.
2. Bonfill X. Cáncer y calidad de vida. Med Clin (Bare) 1990; 95: 106-109.
3. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1948; 1: 634-656.
4. Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis 1979; 32: 661-666.
5. Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B et al. Appraisal of methods for the study of chemotherapy of cancer in man. Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960; 11: 7-33.
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ at al. The European Organization for Research and Treatment of Cancer QLQ-C30: an instrument for use in international clinical trials in oncology. J Nat Cancer Inst 1993; 85: 365-376.
7. Bergman B, Aeronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality-of-life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur Cancer 1994; 30A: 635-642.
8. Hunt SM, McHewen JD, McKenna S. Measuring health status. Londres: Croom Helm, 1986.
9. Alonso J, Prieto L, Anto JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res 1994; 3: 385-393.
10. Aaronson NK, Beckmann J. The quality of life of cancer patients. Nueva York: Raven Press, 1987.
11. Janssen-Heijnen ML, Gatta G, Forman D, Capocaccia R, Coeberg JW. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer 1998; 34: 2191-2196.
12. Epidemiologia i prevenció del càncer a Catalunya, 1975-1992. Institut Català d'Oncologia. Barcelona: Institut Català d'Oncologia, 1997.
13. Bonfill X. La información sanitaria en la investigación y el control del cáncer: II. Estadísticas de morbilidad. Oncología 1994; 17: 271-276.
14. Registre Hospitalari de Tumors 1997. Institut Català d'Oncologia. Barcelona: Institut Català d'Oncologia, 1997.
15. Treurniet HF, Essink-Bot ML, Mackenbach JP, Van der Maas PJ. Health-related quality of life: an indicator of quality of care? Qual Life Res 1997: 6: 363-369.
16. Bergman B, Aaronson NK. Quality-of-life and cost-effectiveness assessment in lung cancer. Curr Opin Oncol 1995; 7: 138-143.
17. Bonfill X. Epidemiología y oncologia: viejas y nuevas perspectivas [editorial], Neoplasia 1991; 8: 39-40.
18. Hopwood P. Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different? Semin Oncol 1996; 5 (Supl 10): 60-64.
19. Deyo RA, Patrick DL. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989; 27: S254-268.
20. Aaronson NK. Methodologic issues in assessing the quality of life of cancer patients. Cancer 1991; 67: 844-850.
21. Morris J, Perez D, McNoe B. The use of quality of life data in clinical practice. Qual Life Res 1998; 7: 85-91.
22. Deyo RA. The quality of life, research, and care. Ann Intern Med 1991; 114: 695-697.
23. Black N. Developing high quality clinical databases. Br Med J 1997; 315: 381-382.
24. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer. A review of literature from 1970 to 1995. Chest 1998; 113: 467-481.
25. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-567.
26. Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis 1979; 32: 661-666.
27. Schaafsma J, Osoba D. The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 1993; 3: 413-424.
28. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer 1990: 65: 1864-1866.
29. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995; 311: 899-909.
30. Higginson I. Chemotherapy in non-small cell lung cancer. Quality of life was ignored in meta-analysis. Br Med J 1996; 312: 249.
31. Buxton J, White M, Osoba D. Patients experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 1998; 7: 513-519.
32. Black N. Why we need observational studies to evaluate the effective-ness of health care? Br Med J 1996, 312: 1215-1218.